Guggenheim Capital’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-39,097
| Closed | -$289K | – | 2022 |
|
|
2022
Q4 | $289K | Sell |
39,097
-3,931
| -9% | -$29.1K | ﹤0.01% | 1680 |
|
|
2022
Q3 | $425K | Sell |
43,028
-8,567
| -17% | -$84.6K | ﹤0.01% | 1543 |
|
|
2022
Q2 | $563K | Buy |
51,595
+2,793
| +6% | +$30.5K | ﹤0.01% | 1525 |
|
|
2022
Q1 | $552K | Buy |
48,802
+6,582
| +16% | +$74.4K | ﹤0.01% | 1651 |
|
|
2021
Q4 | $662K | Sell |
42,220
-11,759
| -22% | -$184K | ﹤0.01% | 1548 |
|
|
2021
Q3 | $925K | Buy |
53,979
+31,692
| +142% | +$543K | 0.01% | 1450 |
|
|
2021
Q2 | $479K | Buy |
+22,287
| New | +$479K | ﹤0.01% | 1844 |
|
|
2014
Q4 | – | Sell |
-146,195
| Closed | -$1.52M | – | 3078 |
|
|
2014
Q3 | $1.52M | Buy |
146,195
+17,039
| +13% | +$177K | ﹤0.01% | 1937 |
|
|
2014
Q2 | $2.09M | Sell |
129,156
-16,992
| -12% | -$275K | 0.01% | 1756 |
|
|
2014
Q1 | $2.38M | Sell |
146,148
-12,026
| -8% | -$195K | 0.01% | 1631 |
|
|
2013
Q4 | $1.96M | Buy |
+158,174
| New | +$1.96M | 0.01% | 1768 |
|